Tech Company Financing Transactions

Biodesy Funding Round

Biodesy closed a $20 million Series C funding round on 9/11/2018. Backers included Alexandria Venture Investments, 5AM Ventures and Pfizer Venture Investments.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

170 Harbor Way 100
San Francisco, CA 94080
USA

Phone

(650) 871-8716

Website

www.biodesy.com

Email Address

[email protected]

Overview

Biodesy is developing technology to directly measure both changes in protein shape and function in real time.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Ariel Notcovich

        

Chief Financial Officer

Gayle Kuokka

        

VP - Engineering

Lou Dietz

        

Browse more venture capital transactions:

Prev: 9/11/2018: Facet Wealth venture capital transaction
Next: 9/11/2018: NewtonX venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary